FDA official logo
GSRS logoPFDA official logo

RILTOZINAMERAN

UNII:72JR7XDV94
Type:INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:RILTOZINAMERAN
GSRS Full Record:
72JR7XDV94
i

  • 2749948-25-0
  • BNT162B2_B.1.1.529
  • MESSENGER RNA (MRNA), 5'-CAPPED, ENCODING A FULL-LENGTH, CODON-OPTIMISED PRE-FUSION STABILISED CONFORMATION VARIANT (K983P AND V984P) OF THE SARS-COV-2 (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; OMICRON VARIANT AND B.1.1.529 AND HCOV-19/BOTSWANA/R42B5_BHP_AAC25114/2021 AND GISAID: EPI_ISL_6752026) SPIKE (S) GLYCOPROTEIN, FLANKED BY 5' AND 3' UNTRANSLATED REGIONS AND A 3' POLY(A) TAIL AND CONTAINS N1-ETHYLPSEUDOURIDINE INSTEAD OF URIDINE (ALL-U>M1.PSI.)
  • RNA (RECOMBINANT 5'-(1,2-((3'-O-METHYL)M7G-(5'->5')-PPP-AM))-CAPPED ALL URIDINE->N1-METHYLPSEUDOURIDINE-SUBSTITUTED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN SECRETORY SIGNAL PEPTIDE PLUS CODON-OPTIMIZED SPIKE GLYCOPROTEIN B.1.1.529 VARIANT-SPECIFYING PLUS 5'-AND 3'-UNTRANSLATED FLANKING REGION-CONTAINING POLY(A)-TAILED MESSENGER BNT162B2_B.1.1.529), INNER SALT
  • Riltozinameran [WHO-DD]
  • riltozinameran [INN]




UNII - 72JR7XDV94 | UNII Search Service